Higher Doses of Rifampin Appear More Effective in Fighting TB Without Increasing Risk of Adverse Events
Drug Used to Treat Daytime Sleepiness Does Not Appear to Improve Driving in Those with Sleep Apnea
Smoking Cessation Drug May Increase Risk of Adverse Cardiovascular Event
Monoclonal Antibody Given to Preterm Babies May Reduce Wheeze Later
Preterm babies given the monoclonal antibody palivizumab to prevent respiratory syncytial virus (RSV) also appear less likely to develop recurrent wheeze, at least until the age of six, according to new research published online, ahead of print in the American Thoracic Society’s American Journal of Respiratory and Critical Medicine. In “Palivizumab Prophylaxis in Preterm Infants and Subsequent Recurrent…